CARDIFF ONCOLOGY, INC. Net Cash Provided by (Used in) Continuing Operations
CARDIFF ONCOLOGY, INC. (CRDF) reported Net Cash Provided by (Used in) Continuing Operations of -$661.86 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2019-08-08
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) continuing operations for the quarter ending 2019-06-30 was -$538.81K, a 104.56% decline year-over-year.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) continuing operations for the quarter ending 2019-03-31 was -$123.05K.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) continuing operations for the quarter ending 2018-12-31 was -$3.61M, a 556.47% decline year-over-year.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) continuing operations for the quarter ending 2018-09-30 was -$3.42M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) continuing operations for fiscal 2018 was $3.23M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) continuing operations for fiscal 2017 was -$5.69M.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) continuing operations for fiscal 2016 was -$53.58M, a 233.28% decline from fiscal 2015.
- CARDIFF ONCOLOGY, INC. net cash provided by (used in) continuing operations for fiscal 2015 was $40.20M, a 2659.31% increase from fiscal 2014.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month | Net Cash Provided by (Used in) Continuing Operations 152 month | Net Cash Provided by (Used in) Continuing Operations 155 month | Net Cash Provided by (Used in) Continuing Operations 158 month | Net Cash Provided by (Used in) Continuing Operations 161 month | Net Cash Provided by (Used in) Continuing Operations 164 month | Net Cash Provided by (Used in) Continuing Operations 167 month | Net Cash Provided by (Used in) Continuing Operations 170 month | Net Cash Provided by (Used in) Continuing Operations 173 month | Net Cash Provided by (Used in) Continuing Operations 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019-06-30 | -$538.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$661.86K 10-Q · filed 2019-08-08 | -$4.27M derived: sum of 3 quarters · filed 2019-08-08 | -$7.69M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||
| 2019-03-31 | -$123.05K 10-Q · filed 2019-05-07 | -$3.74M derived: sum of 2 quarters · filed 2019-05-07 | -$7.16M derived: sum of 3 quarters · filed 2019-05-07 | $4.67M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||
| 2018-12-31 | -$3.61M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | -$7.03M derived: sum of 2 quarters · filed 2019-03-06 | $4.80M derived: sum of 3 quarters · filed 2019-08-08 | $3.23M 10-K · filed 2019-03-06 | |||||||||
| 2018-09-30 | -$3.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $8.41M derived: sum of 2 quarters · filed 2019-08-08 | $6.84M 10-Q · filed 2018-11-07 | $7.63M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||
| 2018-06-30 | $11.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $10.26M 10-Q · filed 2019-08-08 | $11.05M derived: sum of 3 quarters · filed 2019-08-08 | $10.70M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||
| 2018-03-31 | -$1.57M 10-Q · filed 2019-05-07 | -$777.14K derived: sum of 2 quarters · filed 2019-05-07 | -$1.13M derived: sum of 3 quarters · filed 2019-05-07 | -$3.53M derived: sum of 4 quarters · filed 2019-05-07 | |||||||||
| 2017-12-31 | $791.47K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $441.87K derived: sum of 2 quarters · filed 2019-03-06 | -$1.96M derived: sum of 3 quarters · filed 2019-03-06 | -$5.69M 10-K · filed 2019-03-06 | |||||||||
| 2017-09-30 | -$349.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$2.75M derived: sum of 2 quarters · filed 2018-11-07 | -$6.48M 10-Q · filed 2018-11-07 | -$15.13M derived: sum of 4 quarters · filed 2018-11-07 | |||||||||
| 2017-06-30 | -$2.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$6.13M 10-Q · filed 2018-08-03 | -$14.79M derived: sum of 3 quarters · filed 2018-08-03 | -$14.80M derived: sum of 4 quarters · filed 2018-08-03 | |||||||||
| 2017-03-31 | -$3.73M 10-Q · filed 2018-05-08 | -$12.39M derived: sum of 2 quarters · filed 2018-05-08 | -$12.40M derived: sum of 3 quarters · filed 2018-05-08 | -$49.81M derived: sum of 4 quarters · filed 2018-05-08 | |||||||||
| 2016-12-31 | -$8.65M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | -$8.66M derived: sum of 2 quarters · filed 2018-02-26 | -$46.07M derived: sum of 3 quarters · filed 2018-02-26 | -$53.58M 10-K · filed 2018-02-26 | |||||||||
| 2016-09-30 | -$9.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | -$37.42M derived: sum of 2 quarters · filed 2017-11-09 | -$44.92M 10-Q · filed 2017-11-09 | -$51.58M derived: sum of 4 quarters · filed 2017-11-09 | |||||||||
| 2016-06-30 | -$37.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$44.91M 10-Q · filed 2017-08-09 | -$51.57M derived: sum of 3 quarters · filed 2017-08-09 | -$18.71M derived: sum of 4 quarters · filed 2017-08-09 | |||||||||
| 2016-03-31 | -$7.50M 10-Q · filed 2017-05-10 | -$14.16M derived: sum of 2 quarters · filed 2017-05-10 | $18.70M derived: sum of 3 quarters · filed 2017-05-10 | $15.99M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||
| 2015-12-31 | -$6.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $26.20M derived: sum of 2 quarters · filed 2017-03-15 | $23.50M derived: sum of 3 quarters · filed 2017-03-15 | $40.20M 10-K · filed 2017-03-15 | |||||||||
| 2015-09-30 | $32.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $30.15M derived: sum of 2 quarters · filed 2016-11-09 | $46.86M 10-Q · filed 2016-11-09 | $42.99M derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2015-06-30 | -$2.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $14.00M 10-Q · filed 2016-08-04 | $10.13M derived: sum of 3 quarters · filed 2017-03-15 | $6.62M derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2015-03-31 | $16.70M 10-Q · filed 2016-05-10 | $12.83M derived: sum of 2 quarters · filed 2017-03-15 | $9.32M derived: sum of 3 quarters · filed 2017-03-15 | $21.12M derived: sum of 4 quarters · filed 2017-03-15 | |||||||||
| 2014-12-31 | -$3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$7.38M derived: sum of 2 quarters · filed 2017-03-15 | $4.42M derived: sum of 3 quarters · filed 2017-03-15 | $1.46M 10-K · filed 2017-03-15 | |||||||||
| 2014-09-30 | -$3.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $8.29M derived: sum of 2 quarters · filed 2015-11-09 | $5.33M 10-Q · filed 2015-11-09 | $3.36M derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-06-30 | $11.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $8.84M 10-Q · filed 2015-08-10 | $6.87M derived: sum of 3 quarters · filed 2016-03-10 | $26.37M derived: sum of 4 quarters · filed 2016-03-10 | |||||||||
| 2014-03-31 | -$2.97M 10-Q · filed 2015-05-05 | -$4.93M derived: sum of 2 quarters · filed 2016-03-10 | $14.57M derived: sum of 3 quarters · filed 2016-03-10 | $13.71M derived: sum of 4 quarters · filed 2016-03-10 | $22.87M 10-Q · filed 2014-05-12 | ||||||||
| 2013-12-31 | -$1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $17.53M derived: sum of 2 quarters · filed 2016-03-10 | $16.67M derived: sum of 3 quarters · filed 2016-03-10 | $15.02M 10-K · filed 2016-03-10 | $25.84M 10-K · filed 2014-03-17 | ||||||||
| 2013-09-30 | $19.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $18.64M derived: sum of 2 quarters · filed 2014-11-06 | $16.98M 10-Q · filed 2014-11-06 | $19.98M derived: sum of 4 quarters · filed 2015-03-12 | $27.80M 10-Q · filed 2013-11-14 | ||||||||
| 2013-06-30 | -$861.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | -$2.52M 10-Q · filed 2014-08-07 | $487.16K derived: sum of 3 quarters · filed 2015-03-12 | -$1.00M derived: sum of 4 quarters · filed 2015-03-12 | $8.30M 10-Q · filed 2013-08-14 | ||||||||
| 2013-03-31 | -$1.66M 10-Q · filed 2014-05-12 | $1.35M derived: sum of 2 quarters · filed 2015-03-12 | -$140.13K derived: sum of 3 quarters · filed 2015-03-12 | $8.58M derived: sum of 4 quarters · filed 2015-03-12 | $9.16M 10-Q · filed 2013-05-14 | ||||||||
| 2012-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.52M derived: sum of 2 quarters · filed 2015-03-12 | $10.23M derived: sum of 3 quarters · filed 2015-03-12 | $10.12M 10-K · filed 2015-03-12 | $10.82M 10-K · filed 2013-04-01 | ||||||||
| 2012-09-30 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $7.23M derived: sum of 2 quarters · filed 2013-11-14 | $7.11M 10-Q · filed 2013-11-14 | $7.66M derived: sum of 4 quarters · filed 2014-03-17 | $7.82M 10-Q · filed 2012-11-14 | ||||||||
| 2012-06-30 | $8.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $8.60M 10-Q · filed 2013-08-14 | $9.15M derived: sum of 3 quarters · filed 2014-03-17 | $9.29M derived: sum of 4 quarters · filed 2014-03-17 | $9.30M 10-Q · filed 2012-08-14 | ||||||||
| 2012-03-31 | -$113.60K 10-Q · filed 2013-05-14 | $429.31K derived: sum of 2 quarters · filed 2014-03-17 | $571.50K derived: sum of 3 quarters · filed 2014-03-17 | $498.25K derived: sum of 4 quarters · filed 2014-03-17 | $586.78K 10-Q · filed 2012-05-15 | ||||||||
| 2011-12-31 | $542.91K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $685.09K derived: sum of 2 quarters · filed 2014-03-17 | $611.85K derived: sum of 3 quarters · filed 2014-03-17 | $641.67K 10-K · filed 2014-03-17 | |||||||||
| 2011-09-30 | $142.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $68.94K derived: sum of 2 quarters · filed 2012-11-14 | $98.76K 10-Q · filed 2012-11-14 | ||||||||||
| 2011-06-30 | -$73.24K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$43.42K 10-Q · filed 2012-08-14 | |||||||||||
| 2011-03-31 | $29.82K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |